Acquirer | Target | Price |
---|---|---|
Astellas Pharma | Ocata Therapeutics | $379 million |
Apollo Global Management | RegionalCare Hospital Partners | N/A |
Virginia Mason Health System | Memorial Family of Services | Merger |
Janssen Biotech | Rights to oxyntomodulin-based therapies | $105 million |